Literature DB >> 3661454

Effects of antihypertensive drugs on plasma lipids.

H Nakamura1.   

Abstract

Among the risk factors associated with atherosclerotic coronary artery diseases, systemic hypertension and disorders of plasma lipoproteins and apoproteins are very important. Blood lipid changes have been reported with a number of antihypertensive drugs and may conceivably reduce the coronary artery disease-protective benefits of blood pressure reduction. The prevalence of various types of hyperlipoproteinemia among Japanese is discussed, with special reference to the frequency of atherosclerotic vascular diseases. Data concerning the effects of commonly prescribed antihypertensive drugs on blood lipids and apolipoproteins are reported.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661454     DOI: 10.1016/0002-9149(87)90538-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Effects of acebutolol on the serum lipid profile.

Authors:  A Clucas; N Miller
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Effects of beta-blockers on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts.

Authors:  H Yoshida; M Suzukawa; T Ishikawa; H Shige; E Nishio; H Hosoai; M Ayaori; H Nakamura
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  Effects of ketanserin tartrate on serum lipids in patients with essential hypertension.

Authors:  H Nakamura; F Hirata; T Yasugi; M Mizuno; E Saito; T Ishikawa; N Tada; N Nakaya; Y Homma; I Takeuchi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Effect of ketanserin tartrate on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts.

Authors:  M Suzukawa; H Nakamura
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  The Effects of gamma-Aminobutyric Acid, Vinegar, and Dried Bonito on Blood Pressure in Normotensive and Mildly or Moderately Hypertensive Volunteers.

Authors:  Hiroko Tanaka; Kenichi Watanabe; Meilei Ma; Masao Hirayama; Takashi Kobayashi; Hiroshi Oyama; Yoshiko Sakaguchi; Mitsuo Kanda; Makoto Kodama; Yoshifusa Aizawa
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

6.  Effects of ketanserin tartrate on 3-hydroxy, 3-methylglutaryl coenzyme A reductase activity in cultured human skin fibroblasts.

Authors:  M Suzukawa; H Nakamura
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

7.  Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.

Authors:  H Seguchi; H Nakamura; N Aosaki; Y Homma; Y Mikami; S Takahashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.